THE success of chronic hemodialysis in terminal renal failure depends on repeated access to blood vessels that will provide a continuous flow of up to 250 to 300 ml. per minute. A technic was ...

Hyperphosphatemia and hypercalcemia are independently associated with an increased risk of cardiovascular calcification and mortality in patients on dialysis. Sevelamer hydrochloride has the ...

The LifeSite subcutaneous access system allows immediate hemodialysis after implantation. The device consists of a silicone cannula, which is placed in a central venous location (usually via the ...

Purpose. The feasibility of using a limitedsampling algorithm for administration of vancomycin for treatment of vascular-access-related bacteremia in outpatient high flux hemodialysis was ...

BEVERLY, Mass., Nov. 4, 2024 /PRNewswire/ -- Award-winning medical technology innovator, Quanta Dialysis Technologies®, has confirmed the US Food and Drug Administration (FDA) has given 510(k ...

A 25-year-old woman with vitiligo universalis, a severe form of vitiligo that causes nearly complete loss of skin color ...

Quanta Dialysis Technologies has raised $60 million to expand its U.S. commercial presence for its Quanta dialysis system.

Detailed price information for Merit Medical Sys (MMSI-Q) from The Globe and Mail including charting and trades.